+Open data
-Basic information
Entry | Database: PDB / ID: 5ogi | ||||||
---|---|---|---|---|---|---|---|
Title | Complex of a binding protein and human adenovirus C 5 hexon | ||||||
Components |
| ||||||
Keywords | VIRAL PROTEIN / Antibody / Human Adenovirus C5 / gene therapy | ||||||
Function / homology | Function and homology information T=25 icosahedral viral capsid / microtubule-dependent intracellular transport of viral material towards nucleus / host cell / viral capsid / symbiont entry into host cell / host cell nucleus / structural molecule activity Similarity search - Function | ||||||
Biological species | Mus musculus (house mouse) Human adenovirus C serotype 5 | ||||||
Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.8 Å | ||||||
Authors | Schmid, M. / Ernst, P. / Honegger, A. / Suomalainen, M. / Zimmermann, M. / Braun, L. / Stauffer, S. / Thom, C. / Dreier, B. / Eibauer, M. ...Schmid, M. / Ernst, P. / Honegger, A. / Suomalainen, M. / Zimmermann, M. / Braun, L. / Stauffer, S. / Thom, C. / Dreier, B. / Eibauer, M. / Kipar, A. / Vogel, V. / Greber, U.F. / Medalia, O. / Plueckthun, A. | ||||||
Citation | Journal: Nat Commun / Year: 2018 Title: Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control. Authors: Markus Schmid / Patrick Ernst / Annemarie Honegger / Maarit Suomalainen / Martina Zimmermann / Lukas Braun / Sarah Stauffer / Cristian Thom / Birgit Dreier / Matthias Eibauer / Anja Kipar / ...Authors: Markus Schmid / Patrick Ernst / Annemarie Honegger / Maarit Suomalainen / Martina Zimmermann / Lukas Braun / Sarah Stauffer / Cristian Thom / Birgit Dreier / Matthias Eibauer / Anja Kipar / Viola Vogel / Urs F Greber / Ohad Medalia / Andreas Plückthun / Abstract: Most systemic viral gene therapies have been limited by sequestration and degradation of virions, innate and adaptive immunity, and silencing of therapeutic genes within the target cells. Here we ...Most systemic viral gene therapies have been limited by sequestration and degradation of virions, innate and adaptive immunity, and silencing of therapeutic genes within the target cells. Here we engineer a high-affinity protein coat, shielding the most commonly used vector in clinical gene therapy, human adenovirus type 5. Using electron microscopy and crystallography we demonstrate a massive coverage of the virion surface through the hexon-shielding scFv fragment, trimerized to exploit the hexon symmetry and gain avidity. The shield reduces virion clearance in the liver. When the shielded particles are equipped with adaptor proteins, the virions deliver their payload genes into human cancer cells expressing HER2 or EGFR. The combination of shield and adapter also increases viral gene delivery to xenografted tumors in vivo, reduces liver off-targeting and immune neutralization. Our study highlights the power of protein engineering for viral vectors overcoming the challenges of local and systemic viral gene therapies. | ||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 5ogi.cif.gz | 695.4 KB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb5ogi.ent.gz | 584.6 KB | Display | PDB format |
PDBx/mmJSON format | 5ogi.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Summary document | 5ogi_validation.pdf.gz | 500 KB | Display | wwPDB validaton report |
---|---|---|---|---|
Full document | 5ogi_full_validation.pdf.gz | 506.9 KB | Display | |
Data in XML | 5ogi_validation.xml.gz | 43.5 KB | Display | |
Data in CIF | 5ogi_validation.cif.gz | 60.8 KB | Display | |
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/og/5ogi ftp://data.pdbj.org/pub/pdb/validation_reports/og/5ogi | HTTPS FTP |
-Related structure data
Related structure data | 3821C 6eqcC 3tg7S S: Starting model for refinement C: citing same article (ref.) |
---|---|
Similar structure data |
-Links
-Assembly
Deposited unit |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
Unit cell |
|
-Components
-Protein / Antibody , 2 types, 2 molecules AB
#1: Protein | Mass: 108042.469 Da / Num. of mol.: 1 / Source method: isolated from a natural source / Source: (natural) Human adenovirus C serotype 5 / References: UniProt: P04133 |
---|---|
#2: Antibody | Mass: 27256.225 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Mus musculus (house mouse) / Production host: Spodoptera frugiperda (fall armyworm) |
-Non-polymers , 5 types, 287 molecules
#3: Chemical | ChemComp-SO4 / #4: Chemical | ChemComp-DIO / #5: Chemical | ChemComp-EDO / | #6: Chemical | ChemComp-MES / #7: Water | ChemComp-HOH / | |
---|
-Experimental details
-Experiment
Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
---|
-Sample preparation
Crystal | Density Matthews: 3.76 Å3/Da / Density % sol: 67.28 % |
---|---|
Crystal grow | Temperature: 277 K / Method: vapor diffusion, sitting drop / pH: 6.5 / Details: 1.6 M (NH4)2SO4, 10 % dioxane, 0.1 M MES pH 6.5 |
-Data collection
Diffraction | Mean temperature: 100 K |
---|---|
Diffraction source | Source: SYNCHROTRON / Site: SLS / Beamline: X06SA / Wavelength: 1 Å |
Detector | Type: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Oct 26, 2016 |
Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 |
Reflection | Resolution: 2.8→49.09 Å / Num. obs: 49257 / % possible obs: 100 % / Redundancy: 21.1 % / Rrim(I) all: 0.427 / Net I/σ(I): 9.76 |
Reflection shell | Resolution: 2.8→2.87 Å / Rrim(I) all: 5.467 |
-Processing
Software |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: MOLECULAR REPLACEMENT Starting model: 3TG7 Resolution: 2.8→49.09 Å / SU ML: 0.46 / Cross valid method: THROUGHOUT / σ(F): 1.35 / Phase error: 25.82
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: LAST / Resolution: 2.8→49.09 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS refinement shell |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement TLS params. | Method: refined / Origin x: -73.9868 Å / Origin y: 46.2035 Å / Origin z: -14.4718 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement TLS group | Selection details: all |